Labat AfricaJSE:LAB +66.67% Days Payable is 1,000.33 as of Nov. 2025, which is 296% above its 10-year median of 252.46. The stock has 5 warning signs investors should review. Among 923 Drug Manufacturers companies, Labat Africa ranks better than 95.23% on this metric.
The historical rank and industry rank for Labat Africa's Days Payable or its related term are showing as below:
JSE:LAB'
s Days Payable Range Over the Past 10 Years
Min: 91.93 Med: 252.46 Max: 663.6
Current: 579.25
During the past 13 years, Labat Africa's highest Days Payable was 663.60. The lowest was 91.93. And the median was 252.46.
JSE:LAB's Days Payable is ranked better than 95.23% of 923
companies
in the Drug Manufacturers industry
Industry Median: 90.98
vs JSE:LAB: 579.25
Labat Africa's Days Payable
increased
from Nov. 2024 (325.84) to Nov. 2025 (1,000.33).
It may suggest that Labat Africadelayed paying its suppliers.
Labat Africa Days Payable Related Terms
Labat Africa Days Payable Historical Data
* Premium members only.
The historical data trend for Labat Africa's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:LAB vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labat Africa Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labat Africa's Days Payable distribution charts can be found below:
* The bar in red indicates where Labat Africa's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Labat Africa's Days Payable for the fiscal year that ended in May. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labat Africa (JSE:LAB) has a Days Payable of 1,000.33 as of Nov. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Labat Africa and its competitors. This is 296% above median its historical median of 252.46. Over the past decade, Labat Africa's Days Payable has ranged from 91.93 to 663.60. According to the industry distribution chart, Labat Africa ranks #44 out of 923 companies in the Drug Manufacturers industry, placing it in the top 4.8%.
Is Labat Africa's Days Payable too high?
Labat Africa's current Days Payable of 1,000.33 is 296% above median its 10-year median of 252.46. Over the past 10 years, this metric has ranged from a low of 91.93 to a high of 663.60. The Drug Manufacturers industry median Days Payable is 90.98. Labat Africa's value of 1,000.33 is 999.5% above this industry median. Based on the distribution chart, Labat Africa ranks #44 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Labat Africa's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #44 out of 923 companies for Days Payable. This places Labat Africa in the top 5% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.98. Labat Africa's value of 1,000.33 is 999.5% above this benchmark. Historically, Labat Africa's own Days Payable has ranged from 91.93 to 663.60 over the past decade. While the company's 10-year median is 252.46 vs. the industry median of 90.98, Labat Africa has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labat Africa's current Days Payable of 1,000.33 is 999.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Labat Africa and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current Days Payable is 1,000.33, which is 296% above median its own 10-year median of 252.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.05 — trading 77.3% below its estimated fair value. The current Days Payable is 1,000.33, which is 296% above median its 10-year median of 252.46 and 999.5% above the Drug Manufacturers industry median of 90.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current Days Payable is 1,000.33 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:LAB has been successfully added to your 